Pharma Interest Group Meeting - May 2020
Simulation of the Portfolio of COVID-19 Vaccines
Speakers: Vladimir Shnaydman and Jack Scannell
May 21, 2020 (Pharma Interest Group Meeting)
Vladimir and Jack discuss the use of probabilistic approaches and simulation to explore the likelihood of success of COVID-19 vaccine development.